A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for ...

Tezepelumab demonstrated rapid and sustained clinical improvements in nasal polyp burden and symptom control, with effects ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has ...

Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws, and gave ...

Shares of Amgen (AMGN) have been trending lower with the Health Care sector. But the sell off may soon come to an end.

Shares of Cisco Cisco Systems Inc. and Amgen Amgen Inc. have contributed to the blue-chip gauge's intraday rally, as the Dow Dow Jones Industrial Average was most recently trading 222 points (0.5%) ...

Regeneron's lead counsel was Jonathan D. Polkes of White & Case LLP.

U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...

Dow rises as Cisco and Amgen rally, but UnitedHealth drags after DOJ probe. Inflation cools, retail sales steady. Outlook ...

Treatment of optic neuritis with corticosteroids, findings from the Optic Neuritis Treatment Trial and the validity of ...

Asthma biologics can be continued and initiated during conception, throughout pregnancy and while breastfeeding, especially ...